Routine screening for CYP2C19 polymorphisms for patients being treated with clopidogrel is not recommended - Wikidata - awgldk - TriplyDB

Routine screening for CYP2C19 polymorphisms for patients being treated with clopidogrel is not recommended

Routine screening for CYP2C19 polymorphisms for patients being treated with clopidogrel is not recommended

http://www.wikidata.org/entity/Q34990721

about

CYP2C19 and CYP2D6 genotypes in Pacific peoples The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation Leveraging the Learning Health Care Model to Improve Equity in the Age of Genomic Medicine.

P2860

Q38865737-67A5D1D2-EC3F-4E72-837B-30D3EFE9EE87 Q41433207-B2586464-F2CC-4A6E-BD4E-2B9DEFC8BD33 Q53452251-A5B38CEB-3FE6-4191-A707-B5ECC9CBF85B

P2860

Routine screening for CYP2C19 polymorphisms for patients being treated with clopidogrel is not recommended

http://www.wikidata.org/entity/Q34990721

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@ast

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@en

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@nl

type

label

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@ast

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@en

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@nl

prefLabel

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@ast

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@en

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@nl

P1433

Q34990721-ECA55D7D-2B94-41F9-9F7F-594569E4800C

P1476

Q34990721-AA900F23-4448-4E99-8331-002E9D052F77

P2093

Q34990721-0F867D5A-4EEA-4CE3-B611-374CB1BBA673

Q34990721-DB06082D-8D59-40C5-87AD-0A9628248118

Q34990721-E58ED235-6B88-429F-8A84-27D24D00236B

Q34990721-E92D41A5-D9DF-4464-8E87-C6F91973E729

Q34990721-F0552781-F426-4AF5-8CEA-8D555AC01DD7

P2860

Q34990721-011414A6-5159-4534-9AB8-5E719C58D8D9

Q34990721-127F2A6F-44B8-451D-A8AE-009987A5E620

Q34990721-13474D8A-FB6F-42D6-8778-69281D260988

Q34990721-2CB9F9D6-2F6C-43E0-A16B-16C1D8706744

Q34990721-35CBEC4E-7D34-4A60-9CB6-60651501BA31

Q34990721-39A1520E-D7EA-4277-A157-0FCA57C85E55

Q34990721-3BC62CC7-BB25-4FA9-8C5F-DFD0C6DD6EBD

Q34990721-3CCB63E1-D6E2-4E17-AF74-D776226D7B7F

Q34990721-3F05386A-0DD9-41AC-B2FB-439905D5859D

Q34990721-4074B20C-BFE3-434D-84AF-3DE58A78C11D

P304

Q34990721-64393352-ACA0-4944-B1EF-C5B431EEA29B

P31

Q34990721-186A0BF2-8894-4156-9CF3-18ED0849A189

P433

Q34990721-33C8BDDE-2E9F-4EEC-850A-CA42A38B7548

P478

Q34990721-B31923E3-578A-4EE5-883B-13AA86F1E357

P577

Q34990721-AE0A6544-5246-45DF-8DD5-FAA4B4A89A40

P698

Q34990721-BCBE0F1D-3369-4490-8C4B-63D308CAAE50

P921

Q34990721-C421CE7F-0CE9-4673-A665-8B034D5FB2FD

P932

Q34990721-62D2AE79-52BD-4D36-A502-939AA282A579

P1433

Hawaiʻi journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health

P1476

Routine screening for CYP2C19 ...... clopidogrel is not recommended

@en

P2093

Adnan M Bhopalwala

http://www.w3.org/2001/XMLSchema#string

Mona R Valentin

http://www.w3.org/2001/XMLSchema#string

Ramy A Badawi

http://www.w3.org/2001/XMLSchema#string

Robert A Hong

http://www.w3.org/2001/XMLSchema#string

Zia R Khan

http://www.w3.org/2001/XMLSchema#string

P2860

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

Insurance coverage policies for personalized medicine.

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

P304

16-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25628978

http://www.w3.org/2001/XMLSchema#string

P921

P932

4300541

http://www.w3.org/2001/XMLSchema#string